A Novel, Drug Resistance-Independent, Fluorescence-Based Approach To Measure Mutation Rates in Microbial Pathogens
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Measurements of mutation rates—i.e., how often proliferating cells acquire mutations in their DNA—are essential for understanding cellular processes that maintain genome stability. Many traditional mutation rate measurement assays are based on detecting mutations that cause resistance to a particular drug. Such assays typically work well for laboratory strains but have significant limitations when comparing clinical or environmental isolates that have various intrinsic levels of drug tolerance, which confounds the interpretation of results. Here we report the development and validation of a novel method of measuring mutation rates, which detects mutations that cause loss of fluorescence rather than acquisition of drug resistance. Using this method, we measured the mutation rates of clinical isolates of fungal pathogen Candida glabrata . This assay can be adapted to other organisms and used to compare mutation rates in contexts where unequal drug sensitivity is anticipated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The emergence of multi-drug resistant (MDR) C. glabrata isolates is increasing at an alarming rate.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [71]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“it leaves the polyene amphotericin B, which is toxic8, as the only treatment option for these infections.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 1×
“glabrata infections, for which there are no treatment options and which are associated with extremely high mortality (19, 20).”
Self-citationThe changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
A genome-wide view of the spectrum of spontaneous mutations in yeast.
Lynch, M., Sung, W., Morris, K., Coffey, N., Landry, C. R., Dopman, E. B., Dickinson, W. J., Okamoto, K., Kulkarni, S., Hartl, D. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803466105 · Cited by 708
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707
Lee, H., Popodi, E., Tang, H., & Foster, P. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210309109 · Cited by 681
Global trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647 · cited 1×
“However, as described above, comparisons of different clinical isolates are complicated by the variation in their drug resistance profiles, some of which is due to varying activity of drug efflux pumps (14, 15, 18), which is likely to render any drug resistance-based mutation assay inapplicable.”
Self-citationStress-Induced Mutagenesis in Bacteria
Bjedov, I., Tenaillon, O., Gérard, B., Souza, V., Denamur, E., Radman, M., Taddei, F., & Matic, I. (2003) · Science · doi:10.1126/science.1082240 · Cited by 587
Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair
Marsischky, G. T., Filosi, N., Kane, M. F., & Kolodner, R. (1996) · Genes & Development · doi:10.1101/gad.10.4.407 · Cited by 581 · cited 1×
“4A), which is very similar to its effect on mutation rates in S. cerevisiae , where the msh2 (cid:2) effect on CAN1 mutation rate ranges from a 16-to a 40-fold increase, depending on the study (37–40).”
The emerging world of the fungal microbiome
Huffnagle, G. B., & Noverr, M. C. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.04.002 · Cited by 567
DNA Mismatch Repair: Molecular Mechanisms and Biological Function
Schofield, M. J., & Hsieh, P. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090847 · Cited by 492
Determining Mutation Rates in Bacterial Populations
Rosche, W. A., & Foster, P. L. (2000) · Methods · doi:10.1006/meth.1999.0901 · Cited by 482
Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Self-citationHall, B. M., Ma, C.-X., Liang, P., & Singh, K. K. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp253 · Cited by 375
Estimating the Per-Base-Pair Mutation Rate in the Yeast Saccharomyces cerevisiae
Lang, G. I., & Murray, A. W. (2008) · Genetics · doi:10.1534/genetics.107.071506 · Cited by 344 · cited 3×
“The CAN1 mutation assay in Saccharomyces cerevisiae is based on this principle and has been used extensively to gain insights into mechanisms controlling genome stability in yeast (2–5).”
InfluentialPartow, S., Siewers, V., Bjørn, S., Nielsen, J., & Maury, J. (2010) · Yeast · doi:10.1002/yea.1806 · Cited by 334
Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323
Self-citationTran, H. T., Keen, J. D., Kricker, M., Resnick, M. A., & Gordenin, D. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2859 · Cited by 303
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 1×
“However, as described above, comparisons of different clinical isolates are complicated by the variation in their drug resistance profiles, some of which is due to varying activity of drug efflux pumps (14, 15, 18), which is likely to render any drug resistance-based mutation assay inapplicable.”
Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276 · cited 7×
“MSH2 is the C. glabrata homolog of MutS (cid:4) , whose loss has been shown to result in a strong mutator phenotype in all organisms where it has been examined, including C. glabrata (24, 36).”
InfluentialSelf-citationTranscription-dependent recombination and the role of fork collision in yeast rDNA
Takeuchi, Y., Horiuchi, T., & Kobayashi, T. (2003) · Genes & Development · doi:10.1101/gad.1085403 · Cited by 272
Huang, M.-E., Rio, A.-G., Nicolas, A., & Kolodner, R. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2035018100 · Cited by 264
Candidemia and invasive candidiasis in adults: A narrative review
Antinori, S., Milazzo, L., Sollima, S., Galli, M., & Corbellino, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.06.029 · Cited by 257
Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237
Ni, T. T., Marsischky, G. T., & Kolodner, R. D. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80346-9 · Cited by 225
Layton, J. C., & Foster, P. L. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03704.x · Cited by 208
Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata
Poláková, S., Blume, C., Zárate, J. Á., Mentel, M., Jørck-Ramberg, D., Stenderup, J., & Piškur, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809793106 · Cited by 206
Comparative genomics of emerging pathogens in the Candida glabrata clade.
Gabaldón, T., Martin, T., Marcet-Houben, M., Durrens, P., Bolotin-Fukuhara, M., Lespinet, O., Arnaise, S., Boisnard, S., Aguileta, G., Atanasova, R., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-623 · Cited by 198 · cited 1×
“In future studies, the yEGFP-NAT cassette will be integrated at genomic loci more likely to undergo rearrangements, such as subtelomeric loci containing multiple and variable numbers of genes from the adhesin family (52, 53) and ribosomal DNA (rDNA) (54).”
Inhibiting the Evolution of Antibiotic Resistance
Ragheb, M. N., Thomason, M. K., Hsu, C., Nugent, P., Gage, J., Samadpour, A. N., Kariisa, A., Merrikh, C. N., Miller, S. I., Sherman, D. R., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.10.015 · Cited by 192
Roetzer, A., Gabaldón, T., & Schüller, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02102.x · Cited by 154
Evolution in Candida albicans Populations During a Single Passage Through a Mouse Host
Forche, A., Magee, P. T., Selmecki, A., Berman, J., & May, G. (2009) · Genetics · doi:10.1534/genetics.109.103325 · Cited by 147 · cited 1×
“glabrata and other fungal pathogens characterized by frequent genomic rearrangements (26, 50, 51).”
Use of RNA-Protein Complexes for Genome Editing in Non- albicans Candida Species
Grahl, N., Demers, E. G., Crocker, A. W., & Hogan, D. A. (2017) · mSphere · doi:10.1128/msphere.00218-17 · Cited by 133
A counterselection for the tryptophan pathway in yeast: 5-fluoroanthranilic acid resistance
Toyn, J. H., Gunyuzlu, P. L., Hunter White, W., Thompson, L. A., & Hollis, G. F. (2000) · Yeast · doi:10.1002/(sici)1097-0061(200004)16:6<553::aid-yea554>3.0.co;2-7 · Cited by 132
Carreté, L., Ksiezopolska, E., Pegueroles, C., Gómez-Molero, E., Saus, E., Iraola-Guzmán, S., Loska, D., Bader, O., Fairhead, C., & Gabaldón, T. (2018) · Current Biology · doi:10.1016/j.cub.2017.11.027 · Cited by 118 · cited 1×
“However, even strains within the same clade exhibit high genetic diversity (22), which, together with rapid emergence of mutations that cause drug resistance, has led to the hypothesis that C.”
Shor, E., Weinstein, J., & Rothstein, R. J. (2005) · Genetics · doi:10.1534/genetics.104.036764 · Cited by 117
Self-citationMolecular basis of antifungal drug resistance in yeasts
Morio, F., Jensen, R. H., Le Pape, P., & Arendrup, M. C. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.012 · Cited by 114 · cited 1×
“glabrata either is intrinsically resistant or acquires resistance relatively quickly to the limited number of antifungal drugs currently in clinical use (9, 12).”
Timmermans, B., De Las Peñas, A., Castaño, I., & Van Dijck, P. (2018) · Journal of Fungi · doi:10.3390/jof4020060 · Cited by 109
Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system
Enkler, L., Richer, D., Marchand, A. L., Ferrandon, D., & Jossinet, F. (2016) · Scientific Reports · doi:10.1038/srep35766 · Cited by 105
Boyce, K. J., Wang, Y., Verma, S., Shakya, V. P. S., Xue, C., & Idnurm, A. (2017) · mBio · doi:10.1128/mbio.00595-17 · Cited by 101
Role for topoisomerase 1 in transcription-associated mutagenesis in yeast
Lippert, M. J., Kim, N., Cho, J.-E., Larson, R. P., Schoenly, N. E., O'Shea, S. H., & Jinks-Robertson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012363108 · Cited by 97
Liefshitz, B., Steinlauf, R., Friedl, A. A., Eckardt‐Schupp, F., & Kupiec, M. (1998) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(97)00070-0 · Cited by 97
Huang, M.-E., Rio, A.-G., Galibert, M.-D., & Galibert, F. (2002) · Genetics · doi:10.1093/genetics/160.4.1409 · Cited by 97
Saccharomyces cerevisiae Msh2-Msh3 Acts in Repair of Base-Base Mispairs
Harrington, J. M., & Kolodner, R. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00855-07 · Cited by 94
Genetic Drivers of Multidrug Resistance in Candida glabrata
Healey, K. R., Jimenez Ortigosa, C., Shor, E., & Perlin, D. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01995 · Cited by 93 · cited 8×
“Three of these isolates, like ATCC 2001, belonged to ST15 and therefore carried the same MSH2 allele, whereas the other three belonged to ST16, which carries the MSH2E231G/L269F variant (23).”
InfluentialSelf-citationFunctional Characterization of Pathogenic Human MSH2 Missense Mutations in Saccharomyces cerevisiae
Gammie, A. E., Erdeniz, N., Beaver, J., Devlin, B., Nanji, A., & Rose, M. D. (2007) · Genetics · doi:10.1534/genetics.107.071084 · Cited by 88
Expression Plasmids for Use in Candida glabrata
Zordan, R. E., Ren, Y., Pan, S.-J., Rotondo, G., Peñas, A. D. L., Iluore, J., & Cormack, B. P. (2013) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.113.006908 · Cited by 82
Billmyre, R. B., Clancey, S. A., & Heitman, J. (2017) · eLife · doi:10.7554/elife.28802 · Cited by 79
Dellière, S., Healey, K., Gits-Muselli, M., Carrara, B., Barbaro, A., Guigue, N., Lecefel, C., Touratier, S., Desnos-Ollivier, M., Perlin, D. S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02038 · Cited by 75
Self-citationVale-Silva, L., Ischer, F., Leibundgut-Landmann, S., & Sanglard, D. (2013) · Infection and Immunity · doi:10.1128/iai.00074-13 · Cited by 65
Buckland, R. J., Watt, D. L., Chittoor, B., Nilsson, A. K., Kunkel, T. A., & Chabes, A. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004846 · Cited by 64
Chromosomal Rearrangements between Serotype A and D Strains in Cryptococcus neoformans
Sun, S., & Xu, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005524 · Cited by 62
Similar Mutation Rates but Highly Diverse Mutation Spectra in Ascomycete and Basidiomycete Yeasts
Long, H., Behringer, M. G., Williams, E., Te, R., & Lynch, M. (2016) · Genome Biology and Evolution · doi:10.1093/gbe/evw286 · Cited by 59
Lott, T. J., Frade, J. P., & Lockhart, S. R. (2010) · Eukaryotic Cell · doi:10.1128/ec.00002-10 · Cited by 58
Singh, A., Healey, K. R., Yadav, P., Upadhyaya, G., Sachdeva, N., Sarma, S., Kumar, A., Tarai, B., Perlin, D. S., & Chowdhary, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00195-18 · Cited by 56
Self-citationCandida glabrata – unique features and challenges in the clinical management of invasive infections
Glöckner, A., & Cornely, O. A. (2015) · Mycoses · doi:10.1111/myc.12348 · Cited by 49
Biswas, C., Marcelino, V. R., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., Kidd, S., Kennedy, K., Marriott, D., Morrissey, C. O., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02946 · Cited by 49
Lee, G. S. F., Blonsky, K. S., On, D. L. V., Savage, E. A., Morgan, A. R., & von Borstel, R. C. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90978-s · Cited by 40
Hou, X., Xiao, M., Wang, H., Yu, S.-Y., Zhang, G., Zhao, Y., & Xu, Y.-C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-18 · Cited by 40
Bader, O., Schwarz, A., Kraneveld, E. A., Tangwattanchuleeporn, M., Schmidt, P., Jacobsen, M. D., Gross, U., De Groot, P. W. J., & Weig, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052218 · Cited by 39 · cited 1×
“Comparisons of DNA sequences (both of specific genes and of whole genomes) from different C. glabrata clinical isolates have revealed an exceedingly high level of genetic diversity, in terms of both single nucleotide polymorphisms (SNPs) and chromosomal arrangements (21–26).”
Yáñez-Carrillo, P., Orta‐Zavalza, E., Gutiérrez‐Escobedo, G., Patrón‐Soberano, A., Peñas, A. D. L., & Castaño, I. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.04.020 · Cited by 29
MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata
Bordallo-Cardona, M. Á., Agnelli, C., Gómez-Nuñez, A., Sánchez-Carrillo, C., Bouza, E., Muñoz, P., Escribano, P., & Guinea, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01876-18 · Cited by 27 · cited 2×
“This is consistent with several recent clinical studies that did not see an association between MSH2 genotype and prevalence of drug resistance in C. glabrata (27–29, 61, 62).”
Analyzing Genome Rearrangements in Saccharomyces cerevisiae
Srivatsan, A., Putnam, C. D., & Kolodner, R. D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7306-4_5 · Cited by 12
Cited by
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Arastehfar, A., Daneshnia, F., Cabrera, N., Penalva-Lopez, S., Sarathy, J., Zimmerman, M., Shor, E., & Perlin, D. S. (2023) · Nature Communications · doi:10.1038/s41467-023-36882-6 · Cited by 58
Self-citationGarcia-Rubio, R., Hernandez, R. Y., Clear, A., Healey, K. R., Shor, E., & Perlin, D. S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.702779 · Cited by 35
Self-citationGarcia-Rubio, R., Jimenez-Ortigosa, C., DeGregorio, L., Quinteros, C., Shor, E., & Perlin, D. S. (2021) · mBio · doi:10.1128/mbio.01959-21 · Cited by 29
Self-citationBoyce, K. J., Cao, C., Xue, C., & Idnurm, A. (2020) · DNA Repair · doi:10.1016/j.dnarep.2019.102751 · Cited by 14
“In contrast, Cryptococcus strains can gain mutations in many ways within MSH2 (or potentially other MMR pathway genes) without impacting fitness.”
BackgroundMethodInfluential
Metadata
- Authors
- Shor, E., Schuyler, J., & Perlin, D. S.
- Affiliations
- HMH Center for Discovery and Innovation, Nutley, New Jersey, USA
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Perlin, David S.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2019-02-26
- Volume
- 10
- Issue
- 1
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC6391916
- OpenAlex
- W2915379446
- Cited by
- 19
- References
- 62
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 3
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HHS | National Institutes of Health (AI109025)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Keywords
- fluorometric assay, Candida glabrata, fungal pathogens, genome stability, clinical isolates, drug tolerance, fluorescence loss
- MeSH terms
- Alleles, Flow Cytometry, Microbiological Techniques, Molecular Biology, Mutagens, Saccharomyces cerevisiae, Genes, Reporter, Candida glabrata, Green Fluorescent Proteins, MutS Homolog 2 Protein, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.